By Business/Source
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2005/FY
2004/FY
Stock NameRevenueRatio
Preparation product6.7B50.70%
Raw material medicine5.89B44.61%
中间体产品4.02B30.42%
Offset-3.4B-25.72%
By Product
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2005/FY
2004/FY
Stock NameRevenueRatio
抗生素产品7.88B59.68%
胰岛素产品1.88B14.24%
许可费收入1.44B10.92%
6-APA1.21B9.13%
Other797.08M6.03%
By Country/Region
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2016/FY
2015/FY
2014/FY
2013/FY
2012/FY
2011/FY
2009/FY
2008/FY
2007/FY
2006/FY
2005/FY
2004/FY
Stock NameRevenueRatio
中国(包括中国香港)(所在国)9.2B69.63%
Europe2B15.15%
South America843.69M6.39%
Other Asian regions492.85M3.73%
India439.68M3.33%
Other areas195.85M1.48%
Middle East37.65M0.28%
View all
